This is a StreetInsider.com Premium Only Page

Acorda Therapeutics (ACOR) – Major News

Aug 8, 2023 04:48 PM Acorda Therapeutics (ACOR) Reports Q2 Loss of $7.55

May 11, 2023 04:53 PM Acorda Therapeutics (ACOR) Reports Q1 Loss of $0.69

Aug 4, 2022 04:02 PM Acorda Therapeutics (ACOR) Misses Q2 EPS by $2.79

Mar 9, 2022 04:02 PM Acorda Therapeutics (ACOR) Reports Q4 Loss of $0.67

Nov 9, 2021 04:04 PM Acorda Therapeutics (ACOR) Tops Q3 EPS by 13c

Aug 5, 2021 04:02 PM Acorda Therapeutics (ACOR) Tops Q2 EPS by 22c

May 6, 2021 04:51 PM Acorda Therapeutics (ACOR) Tops Q1 EPS by 8c

Mar 4, 2021 04:01 PM Acorda Therapeutics (ACOR) Misses Q4 EPS by 102c

Nov 3, 2020 04:01 PM Acorda Therapeutics (ACOR) Tops Q3 EPS by 7c, Revenues Beat

Aug 4, 2020 04:39 PM Acorda Therapeutics (ACOR) Tops Q2 EPS by 13c

May 5, 2020 04:01 PM Acorda Therapeutics (ACOR) Misses Q1 EPS by 16c

Feb 13, 2020 07:22 AM Acorda Therapeutics (ACOR) Tops Q4 EPS by 25c, Offers Guidance

Nov 4, 2019 04:01 PM Acorda Therapeutics (ACOR) Tops Q3 EPS by 5c, Offers Guidance

Aug 1, 2019 04:02 PM Acorda Therapeutics (ACOR) Tops Q2 EPS by 48c, Revenues Beat; Offers FY19 Sales Guidance

May 2, 2019 06:17 AM Acorda Therapeutics (ACOR) Tops Q1 EPS by 38c, Revenues Beat

Feb 14, 2019 04:01 PM Acorda Therapeutics (ACOR) Tops Q4 EPS by 108c

Jan 17, 2019 06:33 PM Acorda Therapeutics (ACOR) Phase 3 INBRIJA Study Hit Primary Endpoint

Oct 31, 2018 06:16 AM Acorda Therapeutics (ACOR) Tops Q3 EPS by 19c, Revenues Beat; Boosts FY18 AMPYRA Revenue Guidance

Sep 13, 2018 07:03 AM Acorda Therapeutics (ACOR) Says FDA PDUFA Date for INBRIJA Delayed to January 5, 2019

Aug 2, 2018 06:12 AM Acorda Therapeutics (ACOR) Tops Q2 EPS by 68c, Revenues Beat; Offers FY Guidance

May 2, 2018 06:02 AM Acorda Therapeutics (ACOR) Misses Q1 EPS by 33c, Revenues Miss

Feb 15, 2018 06:06 AM Acorda Therapeutics (ACOR) Misses Q4 EPS, Revs Beat

Jan 5, 2018 03:36 PM Acorda Therapeutics (ACOR) Exploring Potential Sale - WSJ

Nov 20, 2017 07:08 AM Acorda Therapeutics (ACOR) Ends Tozadenant Development

Nov 15, 2017 07:02 AM Acorda Therapeutics (ACOR) Says it Increased Frequency of Blood Cell Count Monitoring in its Phase 3 Program of Tozadenant for Parkinson's Disease and Paused New Enrollment

Oct 31, 2017 06:03 AM Acorda Therapeutics (ACOR) Misses Q3 EPS by 22c

Jul 27, 2017 06:04 AM Acorda Therapeutics (ACOR) Misses Q2 EPS by 19c

Apr 27, 2017 06:04 AM Acorda Therapeutics (ACOR) Misses Q1 EPS by 17c

Apr 5, 2017 06:01 AM Acorda Therapeutics (ACOR) to Reduce Headcount by 20% in Restructuring

Mar 31, 2017 12:32 PM Acorda Therapeutics (ACOR) Announces U.S. District Court Issues Decision to Invalidate Four AMPYRA Patents; Plans Appeal

Feb 14, 2017 06:02 AM Acorda Therapeutics (ACOR) Misses Q4 EPS by 6c, Sales Beat

Feb 9, 2017 06:08 AM Acorda Therapeutics (ACOR) Phase 3 Trial CVT-30 Shows Statistically Significant Results

Jan 9, 2017 06:07 AM Acorda Therapeutics (ACOR) 2016 AMPYRA Net Sales Hit $132M, Sees 2017 AMPYRA Net Sales of $535-$545M

Oct 27, 2016 07:56 AM Acorda Therapeutics (ACOR) Misses Q3 EPS by 15c; Reiterates AMPYRA Net Sales Guidance

Jul 28, 2016 10:18 AM Acorda Therapeutics (ACOR) Misses Q2 EPS by 11c

Apr 28, 2016 08:37 AM Acorda Therapeutics (ACOR) Misses Q1 EPS by 1c

Feb 11, 2016 06:00 AM Acorda Therapeutics (ACOR) Tops Q4 EPS by 6c

Oct 22, 2015 06:36 AM Acorda Therapeutics (ACOR) Tops Q3 EPS by 16c

Aug 24, 2015 05:43 PM Acorda Therapeutics (ACOR) Announces PTAB Denial of Both IPRs for AMPYRA Patents

Jul 30, 2015 09:23 AM Acorda Therapeutics (ACOR) Tops Q2 EPS by 14c

Jun 2, 2015 08:49 AM Acorda Therapeutics (ACOR) Phase 1b Clinical Trial of Cimaglermin Alfa Placed on Hold

Apr 30, 2015 06:06 AM Acorda Therapeutics (ACOR) Tops Q1 EPS by 1c

Feb 12, 2015 06:20 AM Acorda Therapeutics (ACOR) Tops Q4 EPS by 32c

Jan 12, 2015 06:52 AM Acorda Therapeutics (ACOR) Prelim. AMPYRA Sales Rose 21% in 2014

Oct 30, 2014 08:02 AM Acorda Therapeutics (ACOR) Reports Q3 EPS of 28c

Sep 24, 2014 07:25 AM Acorda Therapeutics (ACOR) to Acquire Civitas Therapeutics in $525M Cash Deal

Jul 31, 2014 08:15 AM Acorda Therapeutics (ACOR) Tops Q2 EPS by 27c

May 6, 2014 06:06 AM Acorda Therapeutics (ACOR) Tops Q1 EPS by 12c; Updates on Pipeline

Feb 13, 2014 06:13 AM Acorda Therapeutics (ACOR) Tops Q4 EPS by 14c

Oct 31, 2013 06:44 AM Acorda Therapeutics (ACOR) Tops Q3 EPS by 23c